HEALTH (MSM)
(Reuters) – Bristol-Myers Squibb Co said a late-stage trial of its drug, Opdivo, was stopped early after the immunotherapy was found to be effective in patients with the most common form of kidney cancer. The U.S. drugmaker said on Monday the study, Checkmate-025, was stopped early after an independent data monitoring committee concluded that Opdivo provided a survival advantage over the cancer drug, everolimus, among patients with advanced or metastatic
Is there a natural way to quell feelings of anxiety? Hormone Whisperer Alisa Vitti weighs in.
Families affected by the very rarest form of Alzheimer’s, young and inherited, hold crucial clues to fighting this brain-destroying disease in everyone.
Following reports of victims passing out in schools, at home, and even on a motorcycle, and sometimes failing to snap out of it for days at a time, scientists descended on the 600-person village in Kazakhstan.
You’ve probably never noticed it before, but your bottled water has an expiration date. But what does that mean, exactly? Does water go “bad” over time?
Get immediate-arm-gratification from Mary Helen Bowers, the ballerina-turned-celebrity-trainer responsible for turning Natalie Portman into an Oscar-winning dancer for Black Swan.
WASHINGTON (AP) — Alzheimer’s has ravaged generations of Dean DeMoe’s family — his grandmother, father, siblings — all in their 40s and 50s.
By John Tilak TORONTO (Reuters) – Boutique advisory firm INFOR Financial Group said on Sunday it agreed to buy the Canadian operations of U.S. underwriting services provider Incapital Holdings, boosting its presence in the Canadian investment banking market. The acquisition will make Toronto-based INFOR a registered investment dealer and full-service underwriter in the Canadian market, allowing it to provide a broader range of services. The deal also deepens INFOR’s relationship
By John Tilak TORONTO (Reuters) – Boutique advisory firm INFOR Financial Group said on Sunday it agreed to buy the Canadian operations of U.S. underwriting services provider Incapital Holdings, boosting its presence in the Canadian investment banking market. The acquisition will make Toronto-based INFOR a registered investment dealer and full-service underwriter in the Canadian market, allowing it to provide a broader range of services. The deal also deepens INFOR’s relationship
Sometimes you feel like a lab rat/medical experiment gone awry.
